Naphthyridinone derivatives and their use in the treatment of arrhythmia

The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof;Wherein R1, R3-R6, X2 and X3 are as defined herein, a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of phar...

Full description

Saved in:
Bibliographic Details
Main Authors Barbe, Guillaume, Ma, Fupeng, Mo, Ruowei, Yamada, Ken, Gulgeze Efthymiou, Hatice Belgin, Parker, David Thomas, Bebernitz, Gregory Raymond, Peukert, Stefan, Smith, Nichola, Peng, Yunshan, Liao, Lv, Yasoshima, Kayo, Geng, Sicong
Format Patent
LanguageEnglish
Published 20.12.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof;Wherein R1, R3-R6, X2 and X3 are as defined herein, a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
Bibliography:Application Number: US202017071311